Table 3. Relationship between response... | American Society of Hematology

Table 3.

Relationship between response to DLI, disease phase, and interval SCT relapse

Relapse type	Interval SCT relapse
Relapse type	<9 months	>9 months
Molecular (n = 8)^3-150	5/5 (100%)^3-151	3/3 (100%)
Cytogenetic (n = 19)	3/5 (60%)	14/14 (100%)
Hematologic
CP (n = 30)	5/11 (45%)	12/19 (73%)
AP (n = 9)	0/4 (0%)	2/5 (40%)

Relapse type	Interval SCT relapse
Relapse type	<9 months	>9 months
Molecular (n = 8)^3-150	5/5 (100%)^3-151	3/3 (100%)
Cytogenetic (n = 19)	3/5 (60%)	14/14 (100%)
Hematologic
CP (n = 30)	5/11 (45%)	12/19 (73%)
AP (n = 9)	0/4 (0%)	2/5 (40%)

DLI, donor lymphocyte infusion; SCT, stem cell transplantation; CP, chronic phase; AP, advanced phase.

Total number of patients at each disease stage at DLI.

Number of responder/number of patients (percentage).